Economics at your fingertips  

Pharma-Innovationen: Überragende Position der USA und Schwächen der deutschen universitären und außeruniversitären Forschung

Andreas Eckert () and Wolfgang Maennig ()
Additional contact information
Andreas Eckert: Eckert Wagniskapital und Frühphasenfinanzierung GmbH

No 68, Working Papers from Chair for Economic Policy, University of Hamburg

Abstract: We calculate a novel international measure of pharmaceutical innovation power by focusing on global medical breakthroughs and the patents cited therein. This method of calculation is significant (beyond the life sciences) because it measures research performance not in terms of inputs such as research funding or in terms of outputs that are not valued monetarily, such as patent applications and scientific publications, but solely in terms of patents exploited. According to our calculations, companies in the U.S. are responsible for more than half (55%) of the world's medical breakthroughs between 2010 and 2019, while institutions from Germany achieve a share of around 9%. For the anchor patents underlying these breakthroughs, the dominance of the U.S. is even greater at 62% - only 7% of anchor patents come from Germany. US universities hold 3.8% of all anchor patents - German universities none. This weakness of German universities cannot be compensated by German non-university public research institutes such as the Max Planck Society.

Pages: 37 pages
Date: 2021-05-26
New Economics Papers: this item is included in nep-ger
References: Add references at CitEc
Citations: Track citations by RSS feed

Published in Hamburg Contemporary Economic Discussions, Issue 68, 2021

Downloads: (external link) First Version, 2021 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this paper

More papers in Working Papers from Chair for Economic Policy, University of Hamburg Contact information at EDIRC.
Bibliographic data for series maintained by Wolfgang Maennig ().

Page updated 2021-10-13
Handle: RePEc:hce:wpaper:068